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Abstract
Background: Most patients with migraine report photophobia associated with headache; a subset report interictal
photophobia. These patients are light sensitive even during headache-free periods. The objective of this case–
control study was to assess the prevalence of symptoms of anxiety and depression in migraine patients with and
without interictal photophobia.
Methods: We recruited 16 subjects with migraine and interictal photophobia, 16 age- and gender-matched
migraine subjects without interictal photophobia, and 16 age- and gender- matched controls. Migraine subjects
met International Headache Society classification criteria. Participants completed a photophobia questionnaire, Beck
Depression Inventory (BDI-II), and Beck Anxiety Inventory (BAI). Chi-square analyses and two-tailed Wilcoxon rank
sum tests were used for the analyses.
Results: Subjects with interictal photophobia had significantly higher scores on the photophobia questionnaire
compared to subjects without interictal photophobia. Subjects with interictal photophobia had significantly higher
scores on the BDI-II and BAI compared to subjects without interictal photophobia.
Conclusions: Migraine patients with interictal photophobia are more likely to manifest symptoms of depression
and anxiety compared to migraine patients without interictal photophobia. Care providers should be aware of
increased prevalence of these symptoms in this population and consider appropriate referrals. Future research
could assess whether treatment of photophobia leads to improvements in symptoms of depression and anxiety in
migraine patients.
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Background
Photophobia is a general term used to describe light sen-
sitivity or abnormal intolerance of light. Patients with
photophobia avoid light because of pain or discomfort.
In normal subjects, photophobia appears to serve the
function of protecting the retina from damage due to
photo-toxicity [1]. However, patients with an underlying
disorder like migraine have been shown to display con-
siderably greater light sensitivity when compared to con-
trols [2]. Nearly all patients with migraine report
photophobia during headache episodes, but a subset of
these patients report photophobia all the time (“interictal
photophobia”), even during headache–free periods [3].
Furthermore, interictal photophobia associated with mi-
graine may have a negative, and sometimes disabling,
impact on quality of life and social functioning, with the
highest prevalence between the ages of 25 and 55 years,
potentially the most productive period of life [4].
Several studies demonstrate that the presence of
psychiatric co-morbidities is increased in people with
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migraine, especially depression and anxiety [5–10].
There seems to be a bi-directional relationship between
migraine and depression, with each disorder increasing
the risk of the other [11, 12]. Photophobia also was re-
ported in patients with depression [13], but the nature
of this relationship has not been rigorously studied. To
the best of our knowledge, the relationship between
interictal photophobia associated with migraine and de-
pression and anxiety has never been investigated. In this
observational pilot study we wished to better understand
the relationships between interictal photophobia, depres-
sion and anxiety. We hypothesized that individuals with
interictal photophobia and episodic migraine would have
more anxiety and depression than those without interic-
tal photophobia. We approached this question by deter-
mining the prevalence of symptoms of depression and
anxiety in migraine patients with interictal photophobia,
migraine patients without interictal photophobia and a
control group.
Methods
University of Utah IRB approved this study (IRB # 35510).
All authors had full access to all study data. Potential par-
ticipants were recruited from the clinics of three investiga-
tors (BJK, JEAW, KBD). Recruitment and collection of
study data took place between July 2009 and June 2011.
After sending potential participants an introductory letter,
one of the investigators (SML, JEF) contacted each partici-
pant by phone to discuss the study. Subsequently, partici-
pants signed the informed consent document during a
clinic visit, and before completing the study question-
naires. Over a 3 month time we recruited a total of 48
subjects: 16 participants with episodic migraine and inter-
ictal photophobia, 16 age-and gender-matched migraine
subjects without interictal photophobia, and 16 age- and
gender-matched subjects with neither migraine nor
photophobia. All migraine subjects met the International
Classification of Headache Disorders (ICHD) (second edi-
tion) criteria for episodic migraine with or without aura
(i.e., headaches less than 15 days/month) [14]. None were
wearing sunglasses indoors, or spectacles that were specif-
ically tinted for migraine and/or photophobia. None were
being treated for interictal photophobia. We excluded po-
tential subjects with chronic migraine, medication overuse
headache, or chronic tension type headache. We did not
specifically include or exclude subjects with a known his-
tory of depression or anxiety.
We asked each migraine subject whether she/he had
light sensitivity between migraine attacks. If a subject
answered affirmatively, the subject was assigned to the
“migraine with interictal photophobia” group. If they
answered negatively, the subject was placed in the “mi-
graine without interictal photophobia” group. Control
subjects were recruited from family members and others
who accompanied study subjects, and from clinic pa-
tients without episodic migraine. All control subjects
were matched to the other two groups according to age
and gender.
To assess the presence and impact of photophobia,
subjects completed a photophobia questionnaire (Fig. 1).
We developed this questionnaire from questionnaires
that have been used to assess photophobia in previous
investigations [15, 16]. During the same session, subjects
also completed the Beck Depression Inventory II (BDI-
II) and the Beck Anxiety Inventory (BAI), validated
methods to assess for symptoms of depression and anx-
iety, respectively [17–20]. The BDI-II consists of 21
questions, each with a score between 0 and 3. The mini-
mum score is 0 and the maximum score is 63. Scores
between 0 and 13 are scored as “minimal” depression,
scores between 14 and 19 are scored as “mild” depres-
sion, scores between 20 and 28 are scored as “moderate”
depression and scores 29 and above are considered to be
consistent with “severe” depression. The BAI also con-
sists of 21 questions, each with a score between 0 and 3.
Scores between 0 and 21 are interpreted as low anxiety,
scores between 22 and 35 are consistent with moderate
anxiety, and scores greater than or equal to 36 are inter-
preted as evidence of severe anxiety.
Statistical analysis
We used Microsoft Excel 2010 and R 3.2.2 for the ana-
lyses. Pearson chi-square analyses and Wilcoxon rank
sum tests were used to compare the cohorts. A P value
of < 0.05 was considered significant. All tests were two
sided. The sample size was determined by the number of
patients that were seen for photophobia or light sensitiv-
ity while the study was open for enrollment.
Results
The mean age of subjects was 51.5 years and all three
groups consisted of 2 men and 14 women. Using the
photophobia questionnaire, subjects with interictal
photophobia obtained a mean score of 7.9 (standard de-
viation [S.D.] = 3.9), migraine subjects without interictal
photophobia obtained a mean score of 0.9 (S.D. = 0.5)
and control subjects had a mean score of 1.0 (S.D. = 0.7).
The differences between the migraine with interictal photo-
phobia group and the migraine without interictal photo-
phobia group (P < 0.001) and the control group (P < 0.001)
were both statistically significant. The photophobia scores
for the migraine without interictal photophobia group and
the control group were similar (P = 0.756)
The averaged depression inventory total score (i.e., the
sum of the scores of all the subsets) was higher for patients
with migraine with interictal photophobia (mean = 13; S.D.
= 10) than for both migraine patients without interictal
photophobia (mean = 6; S.D. = 4.7; P = 0.021) and controls
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(mean = 6; S.D. = 8.8; P = 0.0245). Seven interictal photo-
phobia subjects had depression inventory total scores that
indicated symptoms of depression that were mild, moderate
or severe. One migraine subject had mild symptoms of de-
pression. Two control subjects had mild symptoms of de-
pression and one control subject had symptoms of severe
depression (Fig. 2).
The averaged anxiety inventory total score was signifi-
cantly higher for patients with migraine and interictal
photophobia (mean = 16; S.D. = 9.8) than for both
migraine patients without interictal photophobia (mean
= 4; S.D. = 3.4; P < 0.001 compared to interictal photo-
phobia) and controls (mean = 5; S.D. = 6.9; P < 0.001
compared to interictal photophobia). Figure 3 illustrates
the marked differences between interictal photophobia
and the other two groups. Thirteen migraine subjects
with interictal photophobia had symptoms of anxiety
that were mild, moderate or severe. One migraine sub-
ject without interictal photophobia had symptoms of
mild anxiety; one control subject had symptoms of mild
Fig. 1 Photophobia questionnaire. This questionnaire was developed based on previous work by our group and by other groups for the
assessment of photophobia in migraine and benign essential blepharospasm, two neurologic disorders that are strongly associated with
photophobia. We developed this version to quantify the severity of light sensitivity and assess its effect on some activities of daily living
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anxiety and one control subject had symptoms of severe
anxiety.
In the process of analyzing the data from the depres-
sion inventory, we noticed a marked difference in the
prevalence of self-reported sleep problems among the
three groups. Twelve of the 16 migraine with interictal
photophobia subjects (75 %) reported changes in sleep-
ing patterns (hypersomnia or insomnia) compared to
seven control subjects (43.75 %) and six migraine with-
out interictal photophobia subjects (37.5 %). This differ-
ence was statistically significant (P = 0.012).
Discussion
Subjects who were assigned to the migraine with interic-
tal photophobia group scored higher on the photophobia
questionnaire than the other two groups. This result
Fig. 2 Depression Inventory scores in migraine subjects with interictal photophobia, migraine subjects without interictal photophobia and a
control group. Subjects with interictal photophobia were more likely to have depression inventory scores consistent with mild, moderate or
severe depression compared to the other two groups
Fig. 3 Anxiety Inventory scores in migraine subjects with interictal photophobia, migraine subjects without interictal photophobia, and a control
group. Subjects with interictal photophobia were far more likely to have anxiety inventory scores consistent with mild, moderate or severe
anxiety compared to the other two groups
Llop et al. The Journal of Headache and Pain  (2016) 17:34 Page 4 of 7
indicates that migraine subjects with interictal photo-
phobia were appropriately assigned to this group based
on the clinical interview. Subjects with migraine without
interictal photophobia had photophobia questionnaire
scores similar to the control group, also indicating that
the migraine subjects without photophobia were
assigned to the appropriate group based on the clinical
interview.
Previous studies have demonstrated an association be-
tween migraine, anxiety and depression [5–10]. Re-
searchers have proposed that the relationship between
migraine, depression and anxiety is bi-directional, that is
that they both influence each other [11, 12]. Previous
work has also demonstrated that migraine patients are
more light sensitive (“photophobic”) than control sub-
jects [15, 21–23], in some cases even between attacks
[3]. Here we have demonstrated that symptoms of de-
pression and anxiety are more prevalent among patients
with migraine with interictal photophobia. We did not
specifically include or exclude subjects with a known
history of depression or anxiety. Photophobia may be a
marker of more severe migraine (although in this study,
not chronic migraine). The mean age of our subjects
was 51 years, perhaps an indication of inter-ictal photo-
phobia acquired over years of migraine. Interictal photo-
phobia could represent central sensitization due to a
lengthy migraine history.
Our study suggests that the relationship between mi-
graine with interictal photophobia, anxiety and depres-
sion may indeed be multidirectional, with each of these
entities influencing the other. To our knowledge, there
have been no studies of anxiety or depression in other
conditions characterized by interictal photophobia (such
as iritis). One study of subjects with tinnitus, another
distressing subjective neuro-sensory symptom, indicated
that report of poor quality of life was mediated by anx-
iety and depression [24].
Our final observation, that subjects with migraine with
interictal photophobia are more likely to report sleep
problems was marked, but perhaps not unexpected,
given the concomitant symptoms of depression and anx-
iety. Animal models also suggest a connection between
emotional brain centers and light sensitivity. Delwig
et al. found that in neonatal mice, which have no formed
vision, light evoked vocalizations similar to vocalizations
interpreted as anxiety of being isolated from the mother,
and patterns of neural activation of the central amygdala
and the posterior thalamic group, brain regions that are
involved in pain processing and photophobia [25, 26].
The correlation between sleep disorders and migraine
with interictal photophobia may be related to the neural
circuits that underlie photophobia [27]. Circadian
rhythms are entrained by the intrinsically photosensitive
retinal ganglion cells of the eye [28]. These same cells
appear to be the origin of a neural pathway that medi-
ates the exacerbation of migraine pain by light [26].
We propose that patients who have migraine and
interictal photophobia may harbor an abnormality in
these neural circuits that results in both photophobia
and disturbances of the sleep cycle. If the link between
symptoms of anxiety and depression and migraine with
interictal photophobia is confirmed by larger studies,
this may offer avenues for treatment. There is good evi-
dence that treating migraine improves depression and
anxiety and that treating depression and anxiety favor-
ably influences the treatment of migraine [12, 29–31].
What remains to be shown is if treatment of photopho-
bia improves depression and/or anxiety?
Our study group was small and recruited from a ter-
tiary care center, and these limitations should be taken
into consideration when extrapolating our results to
other patients with migraine and interictal photophobia.
Nonetheless, we feel that the results we observed in this
small sample merit additional investigation into the inter-
action between migraine, aura, photophobia, depression
and anxiety, particularly by including a larger sample size
from primary care settings that serve a variety of ethnic
populations. Previous studies have documented differ-
ences in the clinical course of those who are members of
ethnic or racial groups other than the Caucasian popula-
tion we encounter in our clinics [32–38]. The photopho-
bia questionnaire we used for this study will provide a
valuable tool for further definition and assessment of these
potentially important differences. We look forward to
such investigations in the future, and we are optimistic
that this line of research will improve our ability to care
for these patients.
Conclusions
Most migraine specialists are aware of the increased
prevalence of depression and anxiety in some of their
patients. Our results indicate that if a migraine patient re-
ports light sensitivity between attacks, they are at higher
risk for these two mental health disorders. Physicians
should consider having such patients evaluated and if ne-
cessary, treated for depression and anxiety. Because of the
higher prevalence of self-reported sleep problems in this
group and because of the adverse influence of poor sleep
on migraine, physicians may also wish to consider inquir-
ing about sleep problems and then recommend further
evaluation or treatment in this group of patients.
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